1,400 results on '"Harris, Stewart"'
Search Results
102. Patient perspectives and experiences of basal insulin (BI) titration in type 2 diabetes (T2D): A US cross-sectional survey
103. Major gaps in diabetes clinical care among Canada's First Nations: Results of the CIRCLE study
104. Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary)
105. Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group
106. Predicting Real-world Hypoglycemia Risk in American Adults With Type 1 or 2 Diabetes Mellitus Prescribed Insulin and/or Secretagogues: Protocol for a Prospective, 12-Wave Internet-Based Panel Survey With Email Support (the iNPHORM [Investigating Novel Predictions of Hypoglycemia Occurrence Using Real-world Models] Study)
107. Pregnancy Family-based Nutrition and Exercise Lifestyle Intervention Program Re-introduced Postpartum Reduces Offspring Fatness at 1-year.: 1409 Board #62 June 2, 9: 00 AM - 10: 30 AM
108. Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis
109. APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians
110. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada
111. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
112. COVID-19 Impact on Diabetes Management (iNPHORM, USA)
113. Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort
114. Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes
115. Author response for 'Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): A 2-year randomized controlled trial'
116. Predicting Real-world Hypoglycemia Risk in American Adults With Type 1 or 2 Diabetes Mellitus Prescribed Insulin and/or Secretagogues: Protocol for a Prospective, 12-Wave Internet-Based Panel Survey With Email Support (the iNPHORM [Investigating Novel Predictions of Hypoglycemia Occurrence Using Real-world Models] Study) (Preprint)
117. COVID-19 hinterland: surveilling the self-reported impacts of the pandemic on diabetes management in the USA (cross-sectional results of the iNPHORM study)
118. Use of once‐weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE C anada multicentre, prospective, observational study
119. Changes in adiposity mediate the associations of diet quality with insulin sensitivity and beta-cell function
120. Which Bible? Which God?
121. The Effect of Physician and Patient Education When Combined with Vardenafil Treatment in Canadian Males with Erectile Dysfunction: An Open-Label, Factorial-Designed, Cluster-Randomized Clinical Trial
122. Use of Ethnographic Methods for Applied Research on Diabetes Among the Ojibway-Cree in Northern Ontario
123. Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review
124. Does a patient-managed insulin intensification strategy with insulin glargine and insulin glulisine provide similar glycemic control as a physician-managed strategy? Results of the start (self-titration with apidra to reach target) study: a randomized noninferiority trial
125. White blood cell subtypes, insulin resistance and β-cell dysfunction in high-risk individuals – the PROMISE cohort
126. Prospective association of 25(OH)D with metabolic syndrome
127. 95-LB: LixilanONE CAN: Randomized Trial Comparing a Daily vs. Weekly Titration Algorithm for Switching from Basal Insulin to iGlarLixi Fixed-Ratio Combination in People with T2DM in Canada
128. 347-P: Why Some Americans Use Health Care following Severe Hypoglycemia, and Why Some Do Not: Baseline Results of the iNPHORM Study
129. Health Care Providers’ Emotional Responses to Their Patients’ Hypoglycemic Events: Qualitative Findings From the InHypo-DM Study, Canada
130. Vulnerable and Forgotten: The Impact of the COVID-19 Pandemic on Autism Special Schools in England
131. Short‐term intensive insulin as induction and maintenance therapy for the preservation of beta‐cell function in early type 2 diabetes ( RESET‐IT Main ): A 2‐year randomized controlled trial
132. Adipose Tissue Insulin Resistance Is Longitudinally Associated With Adipose Tissue Dysfunction, Circulating Lipids, and Dysglycemia: The PROMISE Cohort
133. The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic review
134. Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth
135. The First Amendment and the end of the world.
136. Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes
137. Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes
138. Out-of-pocket Costs of Managing Hyperglycemia and Hypoglycemia in Patients With Type 1 Diabetes and Insulin-treated Type 2 Diabetes
139. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes
140. Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study
141. A pilot school-based healthy eating and physical activity intervention improves diet, food knowledge, and self-efficacy for native Canadian children
142. Giving up grammar and dumping Derrida: how to make legal writing a respected part of the law school curriculum.
143. Results of a Mixed-Methods Evaluation of Partnerships for Health: A Quality Improvement Initiative for Diabetes Care
144. Short Leg Length, a Marker of Early Childhood Deprivation, Is Associated With Metabolic Disorders Underlying Type 2 Diabetes: The PROMISE cohort study
145. Diabetes Management in Canada: Baseline Results of the Group Practice Diabetes Management Study
146. The THEMIS all-sky imaging array—system design and initial results from the prototype imager
147. Nontraditional cardiovascular risk factors in pediatric metabolic syndrome
148. Metabolic syndrome in aboriginal Canadians: Prevalence and genetic associations
149. Prospective Associations of Vitamin D With β-Cell Function and Glycemia: The PROspective Metabolism and ISlet cell Evaluation (PROMISE) Cohort Study
150. Changes Over Time in Glycemic Control, Insulin Sensitivity, and β-Cell Function in Response to Low-Dose Metformin and Thiazolidinedione Combination Therapy in Patients With Impaired Glucose Tolerance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.